XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities    
Net loss $ (120,223,000) $ (43,447,000)
Adjustments to reconcile net loss to cash from operating activities    
Depreciation and amortization 36,970,000 49,155,000
Equity-based compensation expense 5,661,000 5,591,000
Goodwill impairment 57,146,000 0
Loss on asset impairments and retirements 20,532,000 0
Amortization of deferred financing costs 194,000 177,000
Deferred tax provision (benefit) (1,690,000) 3,702,000
Provision for bad debts 1,750,000 85,000
(Gain) loss on disposal of assets (590,000) 381,000
Changes in fair value of investments 813,000 (1,879,000)
Unrealized (gain) loss on derivative instruments 0 204,000
Other (380,000) (373,000)
Changes in operating assets and liabilities    
Accounts receivable 24,465,000 (14,334,000)
Inventories (4,539,000) (2,323,000)
Other current assets 2,272,000 2,063,000
Other assets 390,000 111,000
Accounts payable and accrued liabilities (15,187,000) (17,118,000)
Deferred revenue (226,000) 22,000
Other non-current liabilities (3,212,000) 594,000
Net cash provided by (used in) operating activities 4,146,000 (17,389,000)
Cash flows from investing activities    
Purchases of property, plant and equipment and intangibles (20,259,000) (17,240,000)
Proceeds from sale of assets 6,565,000 260,000
Proceeds from sale of investments 2,832,000 31,739,000
Purchase of investments 0 (20,185,000)
Other (256,000) 0
Net cash used in investing activities (11,118,000) (5,426,000)
Cash flows from financing activities    
Repayments of borrowings 0 (3,492,000)
Treasury shares withheld for taxes (1,086,000) (1,542,000)
Treasury share repurchase (1,498,000) 0
Proceeds from the issuance of ESPP shares 552,000 692,000
Deferred financing costs 0 (184,000)
Net cash used in financing activities (2,032,000) (4,526,000)
Effect of exchange rate changes on cash 6,543,000 (416,000)
Net decrease in cash, cash equivalents and restricted cash (2,461,000) (27,757,000)
Cash, cash equivalents and restricted cash at beginning of period 196,740,000 186,212,000
Cash, cash equivalents and restricted cash at end of period $ 194,279,000 $ 158,455,000